A Study of LY2140023 in Healthy Participants

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
The study will evaluate the effect of activated charcoal on absorption of LY2140023. The study involves a single dose of 80 milligrams (mg) LY2140023 taken as 1 tablet by mouth 2 times during study (once with activated charcoal, once without activated charcoal). This study will last approximately 16 days, not including screening. Screening is required within 28 days prior to study entry.
Epistemonikos ID: 1227881d97b834dabdba0282a6be47c9f40e4ddd
First added on: May 11, 2024